| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.409 | 9.671 | 19.136 | 30.687 | 33.343 | 4.214 | 3.885 | 1.354 | 600 | 637 |
| Total Income - EUR | 2.409 | 9.671 | 19.753 | 30.687 | 33.369 | 7.096 | 6.119 | 1.354 | -991 | 2.467 |
| Total Expenses - EUR | 2.504 | 2.844 | 10.413 | 19.554 | 16.498 | 20.773 | 11.258 | 13.740 | 9.430 | 8.073 |
| Gross Profit/Loss - EUR | -95 | 6.827 | 9.339 | 11.133 | 16.870 | -13.677 | -5.139 | -12.386 | -10.422 | -5.605 |
| Net Profit/Loss - EUR | -167 | 6.589 | 9.129 | 10.736 | 16.537 | -13.716 | -5.251 | -12.427 | -10.440 | -5.605 |
| Employees | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Pharma Services & Promoter Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 628 | 618 | 4.087 | 4.081 | 5.710 | 23.659 | 17.528 | 11.532 | 7.892 |
| Current Assets | 15.772 | 19.708 | 22.059 | 23.145 | 33.426 | 17.983 | 21.541 | 13.377 | 13.988 | 11.555 |
| Inventories | 0 | 11.119 | 9.490 | 9.373 | 9.166 | 11.803 | 14.294 | 11.749 | 11.503 | 10.197 |
| Receivables | 15.753 | 1.596 | 2.669 | 2.226 | 13.956 | 3.710 | 6.115 | 1.588 | 2.445 | 1.322 |
| Cash | 19 | 6.993 | 9.900 | 11.547 | 10.304 | 2.470 | 1.132 | 40 | 41 | 36 |
| Shareholders Funds | 15.349 | 19.644 | 21.963 | 27.139 | 36.916 | 16.302 | 10.689 | -4.160 | -14.526 | -20.050 |
| Social Capital | 225 | 445 | 438 | 430 | 421 | 418 | 408 | 410 | 408 | 406 |
| Debts | 423 | 692 | 714 | 93 | 592 | 7.391 | 34.511 | 35.064 | 40.046 | 39.497 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2899 - 2899" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Pharma Services & Promoter Srl